Edition:
United States

Arcadia Biosciences Inc (RKDA.OQ)

RKDA.OQ on NASDAQ Stock Exchange Capital Market

0.21USD
15 Dec 2017
Change (% chg)

$-0.02 (-8.41%)
Prev Close
$0.23
Open
$0.23
Day's High
$0.23
Day's Low
$0.21
Volume
74,488
Avg. Vol
53,900
52-wk High
$1.38
52-wk Low
$0.18

Latest Key Developments (Source: Significant Developments)

Arcadia Biosciences announces third-quarter financial results
Thursday, 9 Nov 2017 04:05pm EST 

Nov 9 (Reuters) - Arcadia Biosciences Inc :Arcadia Biosciences announces third-quarter and nine-month 2017 financial results and business highlights.Q3 revenue fell 45 percent to $589,000.Q3 loss per share $0.11.  Full Article

Arcadia Biosciences says ‍FDA approval of Arcadia's food additive petition that Sonova GLA safflower oil is safe and nutritious for use in dog diets​
Tuesday, 15 Aug 2017 08:00am EDT 

Aug 15 (Reuters) - Arcadia Biosciences Inc :Arcadia Biosciences - ‍FDA approval of Arcadia's food additive petition that sonova gla safflower oil is safe and nutritious for use in dog diets​.Arcadia Biosciences Inc - ‍Approval allows Arcadia to launch sales of its Sonova GLA safflower oil to pet nutrition companies​.  Full Article

Arcadia Biosciences Q2 loss per share $0.09
Thursday, 10 Aug 2017 04:05pm EDT 

Aug 10 (Reuters) - Arcadia Biosciences Inc ::Arcadia Biosciences announces second-quarter and first-half 2017 financial results and business highlights.Q2 revenue rose 37 percent to $991,000.Q2 loss per share $0.09.  Full Article

Arcadia Biosciences and Dow Agrosciences to develop improved wheat quality trait​
Tuesday, 8 Aug 2017 08:00am EDT 

Aug 8 (Reuters) - Arcadia Biosciences Inc :Arcadia Biosciences - co, ‍dow Agrosciences to collaborate to jointly develop, commercialize a "improved" wheat quality trait in North America​.Arcadia Biosciences Inc - ‍under collaboration, companies will further develop and commercialize an improved wheat quality trait​.Arcadia Biosciences Inc - ‍specific financial and trait details of collaboration were not disclosed​.Arcadia Biosciences - as per deal, Dow Agrosciences will introgress Arcadia's trait into its proprietary elite germplasm lines.As per deal, Dow Agrosciences will manage all aspects related to trait commercialization​.Arcadia Biosciences - ‍certain development costs will be co-funded under collaboration agreement, commercial value will be shared by co, Dow Agrosciences​.  Full Article

Arcadia Biosciences Q1 loss per share $0.10
Wednesday, 10 May 2017 04:05pm EDT 

May 10 (Reuters) - Arcadia Biosciences Inc ::Arcadia Biosciences announces first-quarter 2017 financial results and business highlights.Q1 loss per share $0.10.Q1 revenue rose 19 percent to $1.0 million.Arcadia biosciences inc - cash on hand and liquid investments at end of Q1 totaled $48.5 million.  Full Article

Arcadia says U.S. FDA completes food additive review of co's Sonova® 400 gla safflower oil
Wednesday, 19 Apr 2017 08:00am EDT 

April 19 (Reuters) - Arcadia Biosciences Inc :u.s. Food and drug administration completes food additive review of arcadia biosciences’ sonova® 400 gla safflower oil for use in dog diets.Arcadia biosciences - fda concluded data supports safety, functionality of gla safflower oil as source of omega-6 fatty acids in dry food for adult dogs.Petition will be approved when final rule is published in federal register.  Full Article

Arcadia Biosciences, Vilmorin & Cie say current jv arrangement not best structure to carry out future collaboration
Friday, 7 Apr 2017 05:24pm EDT 

Arcadia Biosciences Inc : Arcadia Biosciences - co and Vilmorin & Cie have determined that current jv arrangement is not best structure to carry out their future collaboration . Arcadia Biosciences - co transferred to U.S. owned subsidiary of Vilmorin & Cie, co's entire membership interest in Limagrain Cereal Seeds - SEC filing .Arcadia Biosciences Inc - U.S. wholly owned subsidiary of Vilmorin & Cie transferred to co 1.8 million shares of co's common stock held by it.  Full Article

Arcadia Biosciences Q4 loss per share $0.13
Wednesday, 8 Mar 2017 04:05pm EST 

Arcadia Biosciences Inc : Arcadia Biosciences announces fourth-quarter and full-year 2016 financial results and business highlights . Q4 loss per share $0.13 . Q4 revenue $540,000 versus $1.3 million . Arcadia Biosciences Inc says realigned its organization to support near-term product commercialization and preserve cash .Arcadia - reorganization included reduction in workforce, management changes and consolidation of facilities to reduce operating expenses by 15-20 percent.  Full Article

Origin, Arcadia announce China Biotechnology collaboration in corn
Wednesday, 22 Feb 2017 08:30am EST 

Origin Agritech Ltd - : Origin, Arcadia announce China biotechnology collaboration in corn . Co and Arcadia announced their collaboration to achieve first-ever export of key corn biotechnology product developed in China . Under agreement Arcadia will assist co in developing information for submission to authorities in U.S., China, other countries .Project involves production of inbred and hybrid seed lines under quarantine conditions in Arcadia greenhouses.  Full Article

Arcadia Biosciences obtains U.S. FDA GRAS status for SONOVA GLA Safflower Oil
Tuesday, 10 Jan 2017 08:00am EST 

Arcadia Biosciences Inc :Arcadia Biosciences obtains U.S. FDA GRAS status for SONOVA GLA Safflower Oil.  Full Article

BRIEF-Arcadia Biosciences announces passing of board chairman George Gosbee

* Arcadia biosciences announces passing of board chairman George Gosbee Source text for Eikon: Further company coverage: